Malti pyrophaline concept stocks are being watched closely, with responses from multiple companies.

Recently, the concept of methylsulfonylmethane (MSM) stocks has emerged, and several listed companies have responded to related issues on interactive platforms. 1. Chengzhi Shares: The company's MSM is still in the trial process. 2. Xianle Health: The company's American subsidiary, Best Formulations, has the ability to produce NAD+ MSM cell energy capsules. The company is very optimistic about the development potential of the anti-aging market. In addition to MSM, the company has also laid out related products such as PQQ, Hesperidin, and Q10 that can be used in anti-aging scenarios. In February of this year, the company announced the establishment of an anti-aging research institute, focusing on cell systems, probiotics and intestines, muscles and joints, and women's ovaries with "scientific research innovation + industrial transformation" as the core. 3. Wanbang Medicine: The company provides clinical efficacy trial services for MSM eye wash projects aimed at improving dry eye syndrome. 4. Fujilai: The company currently has no business related to MSM.